Yun Luan

1.9k total citations
59 papers, 1.5k citations indexed

About

Yun Luan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Yun Luan has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 16 papers in Molecular Biology. Recurrent topics in Yun Luan's work include Pulmonary Hypertension Research and Treatments (14 papers), Mesenchymal stem cell research (9 papers) and Tissue Engineering and Regenerative Medicine (7 papers). Yun Luan is often cited by papers focused on Pulmonary Hypertension Research and Treatments (14 papers), Mesenchymal stem cell research (9 papers) and Tissue Engineering and Regenerative Medicine (7 papers). Yun Luan collaborates with scholars based in China, United States and Sweden. Yun Luan's co-authors include Chao Sun, Feng Kong, Zhaohua Zhang, Jue Wang, Guanghui Cheng, Barbara Murphy, Wen Jiang, Qian Xin, Xue Xia and Yibiao Wang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, British Journal of Cancer and Gene.

In The Last Decade

Yun Luan

58 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yun Luan China 21 489 375 353 311 216 59 1.5k
Stefan Gauer Germany 22 462 0.9× 374 1.0× 122 0.3× 159 0.5× 142 0.7× 42 1.5k
Bing Tu China 18 429 0.9× 290 0.8× 246 0.7× 141 0.5× 232 1.1× 46 1.2k
Wenting Xu China 18 872 1.8× 162 0.4× 206 0.6× 168 0.5× 412 1.9× 46 1.6k
Marcin Bujak United States 15 1.2k 2.5× 568 1.5× 191 0.5× 387 1.2× 242 1.1× 19 2.5k
Kota Ishizawa Japan 16 512 1.0× 295 0.8× 666 1.9× 177 0.6× 170 0.8× 46 1.5k
Yi He China 25 707 1.4× 234 0.6× 168 0.5× 486 1.6× 181 0.8× 88 1.9k
Juha Rutanen Finland 21 991 2.0× 465 1.2× 111 0.3× 152 0.5× 206 1.0× 37 1.7k
Sara Lovisa Italy 13 920 1.9× 238 0.6× 285 0.8× 234 0.8× 304 1.4× 19 1.8k
Jeannette Soria France 27 996 2.0× 426 1.1× 373 1.1× 311 1.0× 639 3.0× 76 2.6k
Yuzo Kodama Japan 21 616 1.3× 491 1.3× 561 1.6× 184 0.6× 242 1.1× 104 2.1k

Countries citing papers authored by Yun Luan

Since Specialization
Citations

This map shows the geographic impact of Yun Luan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Luan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Luan more than expected).

Fields of papers citing papers by Yun Luan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun Luan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Luan. The network helps show where Yun Luan may publish in the future.

Co-authorship network of co-authors of Yun Luan

This figure shows the co-authorship network connecting the top 25 collaborators of Yun Luan. A scholar is included among the top collaborators of Yun Luan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun Luan. Yun Luan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Xia, Huiping Liu, Yan Gao, et al.. (2025). A novel missense mutation Smad4 V354L enhances the efficacy of docetaxel in non-small cell lung cancer. Biomedicine & Pharmacotherapy. 184. 117899–117899.
2.
Zhang, Tong, et al.. (2023). Inhalation of taraxasterol loaded mixed micelles for the treatment of idiopathic pulmonary fibrosis. Chinese Chemical Letters. 35(8). 109248–109248. 7 indexed citations
3.
Xia, Xue, Yingjie Zhang, Yongxiang Liao, et al.. (2021). Design, synthesis and biological evaluation of dual HDAC and VEGFR inhibitors as multitargeted anticancer agents. Investigational New Drugs. 40(1). 10–20. 19 indexed citations
4.
Qian, Xin, Guanghui Cheng, Feng Kong, et al.. (2020). STAT1 transcriptionally regulates the expression of S1PR1 by binding its promoter region. Gene. 736. 144417–144417. 14 indexed citations
5.
Yu, Chao, et al.. (2017). Suppression of TAFI by siRNA inhibits invasion and migration of breast cancer cells. Molecular Medicine Reports. 16(3). 3469–3474. 6 indexed citations
6.
Zhu, Jianguo, Faming Zhang, Yun Luan, et al.. (2016). Can Dynamic Contrast-Enhanced MRI (DCE-MRI) and Diffusion-Weighted MRI (DW-MRI) Evaluate Inflammation Disease. Medicine. 95(14). e3239–e3239. 20 indexed citations
7.
Zhang, Zhaohua, Yanyan Pan, Yun Luan, et al.. (2016). Protective effects of BMSCs in combination with erythropoietin in bronchopulmonary dysplasia-induced lung injury. Molecular Medicine Reports. 14(2). 1302–1308. 14 indexed citations
8.
Jia, Hongying, Jun‐Li Liu, Mingzhen Yuan, et al.. (2015). Regulation Roles of MICA and NKG2D in Human Renal Cancer Cells. Asian Pacific Journal of Cancer Prevention. 16(9). 3901–3905. 3 indexed citations
9.
Guan, Yong, Shuang‐De Liu, Yuqiang Liu, et al.. (2015). Porcine kidneys as a source of ECM scaffold for kidney regeneration. Materials Science and Engineering C. 56. 451–456. 49 indexed citations
10.
Miao, Xinyan, Yun Luan, L.Q. Zhu, et al.. (2014). PAR1‐stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4‐stimulated platelet releasate. Journal of Thrombosis and Haemostasis. 13(3). 465–476. 28 indexed citations
11.
Wang, Yayun, Yun Luan, Xue Zhang, et al.. (2013). Proteasome inhibitor PS-341 attenuates flow-induced pulmonary arterial hypertension. Clinical and Experimental Medicine. 14(3). 321–329. 9 indexed citations
13.
Kong, Feng, Xueying Han, Yun Luan, et al.. (2013). MUTYH Association with Esophageal Adenocarcinoma in a Han Chinese Population. Asian Pacific Journal of Cancer Prevention. 14(11). 6411–6413. 5 indexed citations
14.
Kong, Feng, Yun Luan, Zhaohua Zhang, et al.. (2013). Baicalin protects the myocardium from reperfusion-induced damage in isolated rat hearts via the antioxidant and paracrine effect. Experimental and Therapeutic Medicine. 7(1). 254–259. 32 indexed citations
15.
Luan, Yun, et al.. (2012). Mesenchymal stem cell prevention of vascular remodeling in high flow-induced pulmonary hypertension through a paracrine mechanism. International Immunopharmacology. 14(4). 432–437. 35 indexed citations
16.
Luan, Yun, et al.. (2011). Implantation of Mesenchymal Stem Cells Improves Right Ventricular Impairments Caused by Experimental Pulmonary Hypertension. The American Journal of the Medical Sciences. 343(5). 402–406. 30 indexed citations
17.
Zhang, Guangwei, Xiao‐Cheng Liu, Jesse Li‐Ling, et al.. (2010). Mechanisms of the protective effects of BMSCs promoted by TMDR with heparinized bFGF-incorporated stent in pig model of acute myocardial ischemia. Journal of Cellular and Molecular Medicine. 15(5). 1075–1086. 14 indexed citations
18.
Luan, Yun, Guangwei Zhang, Rongfang Shi, et al.. (2010). Mid-term effect of stem cells combined with transmyocardial degradable stent on swine model of acute myocardial infarction. Coronary Artery Disease. 21(4). 233–243. 8 indexed citations
19.
Krüger, B., Girdhari Lal, Yun Luan, et al.. (2009). Inhibition of TLR4 signaling prolongs Treg-dependent murine islet allograft survival. Immunology Letters. 127(2). 119–125. 28 indexed citations
20.
Luan, Yun, Li Kong, Daniel Howell, et al.. (2008). Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin. Osteoarthritis and Cartilage. 16(11). 1413–1420. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026